BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1735 related articles for article (PubMed ID: 33543942)

  • 21. Biophysical studies of protein misfolding and aggregation in
    Sinnige T; Stroobants K; Dobson CM; Vendruscolo M
    Q Rev Biophys; 2020 Jun; 49():e22. PubMed ID: 32493529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of Alcohol Drinking in Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis.
    Peng B; Yang Q; B Joshi R; Liu Y; Akbar M; Song BJ; Zhou S; Wang X
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32230811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular characterization of the hetero-assembly of β-amyloid peptide with islet amyloid polypeptide.
    Yan LM; Velkova A; Kapurniotu A
    Curr Pharm Des; 2014; 20(8):1182-91. PubMed ID: 23713771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting of Disordered Proteins by Small Molecules in Neurodegenerative Diseases.
    Longhena F; Spano P; Bellucci A
    Handb Exp Pharmacol; 2018; 245():85-110. PubMed ID: 28965171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physico-Pathologic Mechanisms Involved in Neurodegeneration: Misfolded Protein-Plasma Membrane Interactions.
    Shrivastava AN; Aperia A; Melki R; Triller A
    Neuron; 2017 Jul; 95(1):33-50. PubMed ID: 28683268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct Correlation Between Ligand-Induced α-Synuclein Oligomers and Amyloid-like Fibril Growth.
    Nors Perdersen M; Foderà V; Horvath I; van Maarschalkerweerd A; Nørgaard Toft K; Weise C; Almqvist F; Wolf-Watz M; Wittung-Stafshede P; Vestergaard B
    Sci Rep; 2015 May; 5():10422. PubMed ID: 26020724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Faster disease progression in Parkinson's disease with type 2 diabetes is not associated with increased α-synuclein, tau, amyloid-β or vascular pathology.
    de Pablo-Fernández E; Courtney R; Rockliffe A; Gentleman S; Holton JL; Warner TT
    Neuropathol Appl Neurobiol; 2021 Dec; 47(7):1080-1091. PubMed ID: 33969516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein aggregates and proteostasis in aging: Amylin and β-cell function.
    Press M; Jung T; König J; Grune T; Höhn A
    Mech Ageing Dev; 2019 Jan; 177():46-54. PubMed ID: 29580826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protein transmission in neurodegenerative disease.
    Peng C; Trojanowski JQ; Lee VM
    Nat Rev Neurol; 2020 Apr; 16(4):199-212. PubMed ID: 32203399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Type 2 diabetes as a protein misfolding disease.
    Mukherjee A; Morales-Scheihing D; Butler PC; Soto C
    Trends Mol Med; 2015 Jul; 21(7):439-49. PubMed ID: 25998900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cross-talk between amyloidogenic proteins in type-2 diabetes and Parkinson's disease.
    Horvath I; Wittung-Stafshede P
    Proc Natl Acad Sci U S A; 2016 Nov; 113(44):12473-12477. PubMed ID: 27791129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A flash in the pan: dissecting dynamic amyloid intermediates using fluorescence.
    Nath A; Rhoades E
    FEBS Lett; 2013 Apr; 587(8):1096-105. PubMed ID: 23458258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Islet amyloid polypeptide cross-seeds tau and drives the neurofibrillary pathology in Alzheimer's disease.
    Zhang G; Meng L; Wang Z; Peng Q; Chen G; Xiong J; Zhang Z
    Mol Neurodegener; 2022 Jan; 17(1):12. PubMed ID: 35093145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-Amyloid-β Component of Human α-Synuclein Oligomers Induces Formation of New Aβ Oligomers: Insight into the Mechanisms That Link Parkinson's and Alzheimer's Diseases.
    Atsmon-Raz Y; Miller Y
    ACS Chem Neurosci; 2016 Jan; 7(1):46-55. PubMed ID: 26479553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enlightening amyloid fibrils linked to type 2 diabetes and cross-interactions with Aβ.
    Kapurniotu A
    Nat Struct Mol Biol; 2020 Nov; 27(11):1006-1008. PubMed ID: 33097922
    [No Abstract]   [Full Text] [Related]  

  • 36. Copper homeostasis and neurodegenerative disorders (Alzheimer's, prion, and Parkinson's diseases and amyotrophic lateral sclerosis).
    Gaggelli E; Kozlowski H; Valensin D; Valensin G
    Chem Rev; 2006 Jun; 106(6):1995-2044. PubMed ID: 16771441
    [No Abstract]   [Full Text] [Related]  

  • 37. Reduced Abundance and Subverted Functions of Proteins in Prion-Like Diseases: Gained Functions Fascinate but Lost Functions Affect Aetiology.
    Allison WT; DuVal MG; Nguyen-Phuoc K; Leighton PLA
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29064456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nitration in neurodegeneration: deciphering the "Hows" "nYs".
    Reynolds MR; Berry RW; Binder LI
    Biochemistry; 2007 Jun; 46(25):7325-36. PubMed ID: 17542619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. De novo designed protein inhibitors of amyloid aggregation and seeding.
    Murray KA; Hu CJ; Griner SL; Pan H; Bowler JT; Abskharon R; Rosenberg GM; Cheng X; Seidler PM; Eisenberg DS
    Proc Natl Acad Sci U S A; 2022 Aug; 119(34):e2206240119. PubMed ID: 35969734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Shedding light on aberrant interactions - a review of modern tools for studying protein aggregates.
    Kundel F; Tosatto L; Whiten DR; Wirthensohn DC; Horrocks MH; Klenerman D
    FEBS J; 2018 Oct; 285(19):3604-3630. PubMed ID: 29453901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 87.